A gene-protein assay for human epidermal growth factor receptor 2 (HER2): brightfield tricolor visualization of HER2 protein, the <it>HER2</it> gene, and chromosome 17 centromere (CEN17) in formalin-fixed, paraffin-embedded breast cancer tissue sections

Slični predmeti

• Development of automated brightfield double <it>In Situ </it>hybridization (BDISH) application for <it>HER2 g</it>ene and chromosome 17 centromere (CEN 17) for breast carcinomas and an assay performance comparison to manual dual color <it>HER2 </it>fluorescence <it>In Situ </it>hybridization (FISH)
  od: Wang Lin, i dr.
  Izdano: (2008-10-01)
• The Prognostic Impact of HER2 Genetic and Protein Expression in Pancreatic Carcinoma—HER2 Protein and Gene in Pancreatic Cancer
  od: Song-Hee Han, i dr.
  Izdano: (2021-04-01)
• Patterns of HER2 Gene Amplification and Response to Anti-HER2 Therapies.
  od: Rocio Vicario, i dr.
  Izdano: (2015-01-01)
• Breast Cancer With a HER2 IHC2+ and FISH HER2/CEP17 Ratio ≥2.0 and an Average HER2 Gene Copy Number <4.0 per Tumor Cell: HER2 mRNA Overexpression Is a Rare Event
  od: Yuanyuan Liu, i dr.
  Izdano: (2020-06-01)
• The Clinicopathologic and Prognostic Value of Altered Chromosome 17 Centromere Copy Number in HER2 Fish Equivocal Breast Carcinomas.
  od: Hongfei Ji, i dr.
  Izdano: (2015-01-01)